Harrow (HROW) Research & Development (2010 - 2026)
Harrow (HROW) recorded quarterly Research & Development of $5.9 million in Q1 2026, down 49.71% quarter-over-quarter from $11.7 million in Q4 2025, and up 94.81% on a YoY basis from $3.0 million in Q1 2025.
Harrow (HROW) Research & Development (2010 - 2026) Analysis & Trends
Harrow's Research & Development history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.
- In Q1 2026, Research & Development rose 94.81% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $23.8 million (up 81.65% YoY), while the FY2025 annual figure was $20.9 million, up 71.22% from the prior year.
- Research & Development was $5.9 million for Q1 2026 at Harrow, down from $11.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.7 million in Q4 2025 to a low of $658000.0 in Q1 2022.
- Historically, Research & Development has averaged $2.9 million across 5 years, with a median of $2.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 87.35% in 2022, then surged 374.54% in 2023.
- A 5-year view of Research & Development shows it stood at $703000.0 in 2022, then surged by 374.54% to $3.3 million in 2023, then soared by 42.54% to $4.8 million in 2024, then soared by 146.54% to $11.7 million in 2025, then sank by 49.71% to $5.9 million in 2026.
- The last three Research & Development figures came in at $5.9 million (Q1 2026), $11.7 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | 5.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 734,000.00 |
| Dec 31, 2022 | 703,000.00 |
| Sep 30, 2022 | 775,000.00 |
| Jun 30, 2022 | 914,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 6.13 Mn |
| Jun 30, 2021 | 425,000.00 |